FDA head offers guidelines for vaccine to Senate

News

Adm. Brett Giroir, left, director of the U.S. coronavirus diagnostic testing, and Food and Drug Administration (FDA) Commissioner Stephen Hahn, prepare to testify before a Senate Health, Education, Labor and Pensions Committee hearing on Capitol Hill in Washington, Tuesday, June 30, 2020. (Kevin Dietsch/Pool via AP)

WASHINGTON — The head of the Food and Drug Administration says vaccine developers will be expected to study COVID-19 shots in racial minorities, the elderly, pregnant women and those with other health conditions.

FDA Commissioner Stephen Hahn outlined the guidelines for potential vaccines at a Senate hearing on reopening schools and workplaces.

Hahn says “while the FDA is committed to help expedite this work, we will not cut corners in our decision-making.”

The agency has come under criticism for granting emergency authorization to a malaria drug touted by President Donald Trump as a treatment for coronavirus. The agency revoked that designation earlier this month after studies found the drug was ineffective against the virus.

The U.S. is set to begin a 30,000-person trial of a government-created shot starting next month. Under the Trump administration’s program dubbed “Operation Warp Speed,” health officials aim to have 300 million doses on hand by January.

About 15 experimental COVID-19 vaccines are in various stages of testing worldwide. There is no guarantee that any will prove effective.

Copyright 2020 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Graduate Gallery
Livin Upstate Deals
Carolina Eats Contest
Adopt A Thon
wspa news app free for download choose your store below
download the wspa news app from the apple app store
download the wspa news app from the google play store

Trending Stories